Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain
sulfonamide or sulfonamide functionality at the 1-position are useful as
immune response modifiers. The compounds and compositions of the
invention can induce the biosynthesis of various cytokines and are useful
in the treatment of a variety of conditions including viral diseases and
neoplastic diseases.